The same cholesterol drug also made fewer bad cholesterol particles (LDL) in pigs by slowing down how much was made, not by clearing them faster.
Scientific Claim
Atorvastatin treatment at 3 mg/kg per day for 21 days in miniature pigs fed a high-fat, high-cholesterol diet reduces plasma LDL apolipoprotein B production rate by 22% and decreases LDL apolipoprotein B pool size by 30%, with no change in fractional catabolic rate.
Original Statement
“The LDL apoB pool size decreased by 30% (4.74 versus 6.75 mg/kg; P=.0004), which was due to a 22% reduction in the LDL apoB PR (0.236 versus 0.301 mg/kg per hour; P=.004), since the FCR was unchanged.”
Evidence Quality Assessment
Claim Status
overstated
Study Design Support
Design cannot support claim
Appropriate Language Strength
association
Can only show association/correlation
Assessment Explanation
Based on abstract only - full methodology not available to verify. The study design (animal, unknown randomization) cannot support definitive causal claims.
More Accurate Statement
“Atorvastatin treatment at 3 mg/kg per day for 21 days in miniature pigs fed a high-fat, high-cholesterol diet was associated with a 22% reduction in LDL apolipoprotein B production rate and a 30% decrease in LDL apolipoprotein B pool size, with no change in fractional catabolic rate.”
Gold Standard Evidence Needed
According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.
Randomized Controlled TrialLevel 1bIn EvidenceThat atorvastatin directly causes a reduction in LDL apoB production rate in pigs.
That atorvastatin directly causes a reduction in LDL apoB production rate in pigs.
What This Would Prove
That atorvastatin directly causes a reduction in LDL apoB production rate in pigs.
Ideal Study Design
A double-blind, placebo-controlled RCT in 20+ healthy miniature pigs, randomized to receive 3 mg/kg/day atorvastatin or placebo for 21 days while fed identical high-fat, high-cholesterol diets, with LDL apoB production rate measured via multicompartmental analysis using radiolabeled leucine as the primary endpoint.
Limitation: Cannot prove the mechanism is due to reduced VLDL conversion or hepatic mRNA changes.
Prospective CohortLevel 2bWhether the reduction in LDL apoB production is dose-dependent or consistent across different pig populations.
Whether the reduction in LDL apoB production is dose-dependent or consistent across different pig populations.
What This Would Prove
Whether the reduction in LDL apoB production is dose-dependent or consistent across different pig populations.
Ideal Study Design
A prospective cohort study following 50 miniature pigs on a standardized high-fat, high-cholesterol diet, with atorvastatin administered at varying doses (0, 1, 3, 5 mg/kg/day) for 21 days, measuring LDL apoB production rate at baseline and endpoint.
Limitation: Cannot establish causation due to lack of randomization and potential confounding by individual variability.
Animal Study (Non-RCT)Level 4In EvidenceWhether the observed reduction in LDL apoB production is reproducible under identical experimental conditions.
Whether the observed reduction in LDL apoB production is reproducible under identical experimental conditions.
What This Would Prove
Whether the observed reduction in LDL apoB production is reproducible under identical experimental conditions.
Ideal Study Design
A non-randomized animal study in 10 additional miniature pigs treated with 3 mg/kg/day atorvastatin for 21 days under identical dietary and measurement conditions as the original study, using the same apoB kinetic methods.
Limitation: Lacks control group and randomization, so cannot isolate drug effect from time or diet effects.
Evidence from Studies
Supporting (1)
Inhibition of HMG-CoA reductase by atorvastatin decreases both VLDL and LDL apolipoprotein B production in miniature pigs.
The study gave pigs a specific cholesterol-lowering drug for 3 weeks and found it cut the amount of bad cholesterol particles made by the liver by exactly the amount the claim says — and didn’t change how fast those particles were cleared.